EW Stock: Price, Earnings History and SEC Filings
Edwards Lifesciences Corporation (EW) last traded at $92.01, down 2.57% on the latest session and up 6.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.78 against an analyst estimate of $0.73, a beat of 6.8%.
$92.01 -2.57%
1 month+6.59%
52-week high$96.29
52-week low$74.66
Volume6.04M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
EW earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 23, 2026 | $0.78 | $0.73 | +6.85% |
| Mar 2026 | Apr 23, 2026 | $0.78 | $0.75 | +4.00% |
| Dec 2025 | Feb 10, 2026 | $0.58 | $0.62 | -6.45% |
| Sep 2025 | Oct 30, 2025 | $0.67 | $0.59 | +13.56% |
EW beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for EW
SEC filing data is not available right now. You can search for EW on SEC EDGAR.
EW news
- Edwards' Q3 Earnings on the Horizon: What's in the Cards?Oct 30, 2026 · finance.yahoo.com
- Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key MetricsOct 30, 2026 · finance.yahoo.com
- What Sent GE HealthCare Stock Higher?Oct 29, 2026 · trefis.com
- SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?Oct 28, 2026 · finance.yahoo.com
- ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?Oct 28, 2026 · finance.yahoo.com
- WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?Oct 27, 2026 · finance.yahoo.com
- GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?Oct 27, 2026 · finance.yahoo.com
- INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?Oct 23, 2026 · finance.yahoo.com
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) is a US-listed public company on NYSE.